UroToday.com - In the online version of Cancer, Dr. Marc Dall'Era and colleagues at UCSF report on their experience with active surveillance (AS) for prostate cancer (CaP). Active surveillance was offered to men with Gleason score 0.75ng/ml/year occurred in 78 men and 15% had a PSAV 2ng/ml/year. Mean PSA doubling time was 6.
Share This
Tell a friend
Discard
Add to:
|
|
| Bookmarks